台股 » 個股 » 生華科 » 籌碼相關 » 融資融券與借券

生華科

(6492)
可現股當沖
  • 股價
    45.25
  • 漲跌
    ▼0.15
  • 漲幅
    -0.33%
  • 成交量
    91
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生華科 (6492) 融資融券與借券

股票投資新手教室: 一分鐘搞懂「融資融券」

生華科 (6492) 融資融券與借券

生華科 (6492) 近三十日融資融券與借券賣出
日期 融資 融券 資券互抵(張) 資券當沖(%) 券資比(%) 價格 比例 成交量
增加 餘額 使用率% 增加 餘額 使用率%
12/03-12,0669.2100000045.25-0.33%91
12/02-12,0679.2100010.72045.4-1.41%139
11/29362,0689.2200010.51046.053.60%195
11/2832,0329.0600000044.450.57%163
11/2792,0299.0400010.53044.2-1.89%190
11/26-12,020900000045.05-0.88%113
11/2532,0219.0100000045.450.22%88
11/22-212,0188.9900010.41045.35-0.66%242
11/21-22,0399.0900000045.651.22%277
11/2052,0419.100000045.1-0.77%135
11/19-52,0369.08-230000045.453.06%290
11/18-332,0419.123230.130.491.1344.1-4.65%616
11/1552,0749.2400000046.25-0.43%194
11/14292,0699.2200000046.45-1.59%341
11/13332,0409.09-10000047.2-0.32%176
11/12102,0078.95010000.0547.35-2.07%437
11/1101,9978.9010000.0548.35-0.51%193
11/08-731,9978.9010000.0548.6-1.72%539
11/07-262,0709.23-610000.0549.450.20%302
11/0642,0969.34-170.03000.3349.35-0.50%519
11/0522,0929.32380.04000.3849.6-0.20%287
11/04292,0909.32350.02000.2449.7-0.60%390
11/01-322,0619.19-120.01000.150-0.99%451
10/30-442,0939.33-430.01000.1450.5-3.07%713
10/29-682,1379.53170.0310.080.3352.1-0.95%1,326
10/281662,2059.83-1660.03160.220.2752.6-3.31%7,114
10/251962,0399.0922220.1001.0854.49.90%2,109
10/24151,8438.2100000049.5-1.00%211
10/23151,8288.15000000500.81%122
10/22231,8138.0800000049.6-0.60%231
日期 融券 借券賣出 價格 比例 成交量
買進 賣出 增加 餘額 使用率% 賣出 還券 調整 增加 餘額
12/0300000@Limit20070-71,69145.25-0.33%91
12/0200000@Limit200120-121,69845.4-1.41%139
11/2900000@Limit2020021,71046.053.60%195
11/2800000@Limit206160-101,70844.450.57%163
11/2700000@Limit20060-61,71844.2-1.89%190
11/2600000@Limit200170-171,72445.05-0.88%113
11/2500000@Limit2020021,74145.450.22%88
11/2200000@Limit203000301,73945.35-0.66%242
11/2100000@Limit2080081,70945.651.22%277
11/2000000@Limit202400241,70145.1-0.77%135
11/192300-230@Limit202600261,67745.453.06%290
11/1802302323@Limit20.13300331,65144.1-4.65%616
11/1500000@Limit202100211,61846.25-0.43%194
11/1400000@Limit204700471,59746.45-1.59%341
11/13001-10@Limit202100211,55047.2-0.32%176
11/1200001@Limit203200321,52947.35-2.07%437
11/1100001@Limit2060061,49748.35-0.51%193
11/0800001@Limit203900391,49148.6-1.72%539
11/07600-61@Limit203000301,45249.450.20%302
11/06100-17@Limit20.032600261,42249.35-0.50%519
11/0514038@Limit20.043840341,39649.6-0.20%287
11/0414035@Limit20.023590261,36249.7-0.60%390
11/01100-12@Limit20.0160061,33650-0.99%451
10/30510-43@Limit20.015500551,33050.5-3.07%713
10/2901017@Limit20.03140-31,27552.1-0.95%1,326
10/281600-166@Limit20.03155001551,27852.6-3.31%7,114
10/2502202222@Limit20.110011,12354.49.90%2,109
10/2400000@Limit2090091,12249.5-1.00%211
10/2300000@Limit2000001,113500.81%122
10/2200000@Limit208270-191,11349.6-0.60%231
日期 當沖成交張數 買進成交金額 賣出成交金額 現股當沖率(%) 平均盈虧
12/03261,182,6001,183,40028.5730.77
12/02421,909,6001,912,45030.2267.86
11/29391,764,4501,772,20020198.72
11/28231,013,2501,018,10014.11210.87
11/27482,140,1502,150,05025.26206.25
11/2612541,450543,30010.62154.17
11/259408,450409,75010.23144.44
11/22532,424,4502,427,55021.958.49
11/21492,239,7002,243,70017.6981.63
11/2017769,500772,05012.59150
11/19723,234,0503,253,65024.83272.22
11/181677,469,2507,458,50027.11-64.37
11/15231,066,7001,072,70011.86260.87
11/14753,496,4003,496,95021.997.33
11/13311,468,6501,471,40017.6188.71
11/12944,462,6004,493,30021.51326.6
11/11331,599,9001,601,35017.143.94
11/08904,429,6504,425,50016.7-46.11
11/07874,325,9504,335,05028.81104.6
11/061678,340,5508,351,15032.1863.47
11/05522,580,0002,580,35018.126.73
11/041276,356,3006,373,70032.56137.01
11/011045,183,7505,203,65023.06191.35
10/3027113,906,10013,869,90038.01-133.58
10/2971137,595,30037,631,10053.6250.35
10/284,377242,754,400242,865,90061.5325.47
10/2570837,737,80038,029,10033.57411.44
10/24592,965,3502,959,20027.96-104.24
10/23221,097,1501,099,65018.03113.64
10/22492,421,9502,427,55021.21114.29
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音